Has Steven Kawut, MD received payments from drug or device companies?

Yes. Drug and device makers reported $34,461 in general payments to Steven Kawut, MD across 37 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Kawut, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Kawut, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Kawut, MD

Critical Care Medicine · Philadelphia, PANPI 1730254533

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $30,697 of the $34,461 with a category attached, or 89.1%. 5 manufacturers reported payments, led by Merck at 55.5% of the total. 2025 is the largest year on record at $21,598, 7.7 times the $2,800 reported in 2021. Among critical care medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,461in general payments, 2019–2025

Across 37 payments — averaging $931.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$19K
Regeneron$7K
Vivus LLC$5K
Janssen Research & Development, LLC$2K
Amgen$1K

$21,805in research payments, 2019–2025

Across 6 payments — averaging $3634.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

United Therapeutics Corporation$22K

What the payments were for

Consulting fees$30,69789%
Travel & lodging$3,30810%
Food & beverage$4551%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	23	$19,123
Regeneron	9	$6,776
Vivus LLC	2	$5,275
Janssen Research & Development, LLC	1	$2,170
Amgen	2	$1,116

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

WINREVAIR$3,008

How this compares

$34,461 in reported general payments places this provider in the 95th percentile of 354 critical care medicine providers in Pennsylvania.

See all critical care medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$26,245

Medicare patients

Services billed

285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tyvaso DpiTreprostinil	21	$503,517
AdempasRiociguat	15	$219,149
OpsumitMacitentan	16	$208,785
Ambrisentan	25	$105,970
Tadalafil	23	$23,887
EliquisApixaban	13	$8,540
Sildenafil Citrate	33	$8,246
Albuterol Sulfate HfaAlbuterol Sulfate	12	$230
Furosemide	12	$138
Spironolactone	11	$91

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Philadelphia

David DibardinoPhiladelphia$63K
Harold PalevskyPhiladelphia$55K
Kerri SmithPhiladelphia$30K
Michael BeersPhiladelphia$28K
Daniel DorganPhiladelphia$23K
Belinda Rivera-LebronPhiladelphia$18K
Kevin MaPhiladelphia$15K
Joshua DiamondPhiladelphia$13K
Gregory TinoPhiladelphia$9K
Anthony LanfrancoPhiladelphia$8K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →